Trials / Completed
CompletedNCT03546816
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Prurigo Nodularis
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Prurigo Nodularis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 285 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with prurigo nodularis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5mg Serlopitant Tablets | Serlopitant Tablets |
| DRUG | Placebo Tablets | Placebo Tablets |
Timeline
- Start date
- 2018-05-02
- Primary completion
- 2020-01-14
- Completion
- 2020-02-14
- First posted
- 2018-06-06
- Last updated
- 2021-05-20
- Results posted
- 2020-09-07
Locations
49 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03546816. Inclusion in this directory is not an endorsement.